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Abstract Antibiotic resistance is becoming a pivotal
concern for public health that has accelerated the search for
new antimicrobial molecules from nature. Numbers of
human pathogens have inevitably evolved to become
resistant to various currently available drugs causing con-
siderable mortality and morbidity worldwide. It is apparent
that novel antibiotics are urgently warranted to combat
these life-threatening pathogens. In recent years, there have
been an increasing number of studies to discover new
bioactive compounds from plant origin with the hope to
control antibiotic-resistant bacteria. This review attempts
to focus and record the plant-derived compounds and plant
extracts against multi-drug-resistant (MDR) pathogens
including methicillin-resistant Staphylococcus aureus
(MRSA), MDR-Mycobacterium tuberculosis and malarial
parasites Plasmodium spp. reported between 2005 and
2015. During this period, a total of 110 purified compounds
and 60 plant extracts were obtained from 112 different
plants. The plants reviewed in this study belong to 70
different families reported from 36 countries around the
world. The present review also discusses the drug resis-
tance in bacteria and emphasizes the urge for new drugs.
Keywords Plant metabolites  Antibiotic resistance 
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Introduction
Approximately, 500,000 species of both identified and
unidentified plants have been estimated on Earth. Among
them, only 1–10% are being used as foods by animals and
humans (Borris 1996; Cowan 1999). Plants are the key
source for drugs and an alternative medicine for fighting
against diseases since ancient times. Evidential specimens
proved that Neanderthals living 60,000 years ago in pre-
sent-day Iraq used plants such as hollyhock (Thomson
1978; Stockwell 1988; Cowan 1999) and these plants are
still widely being used in ethnomedicine across the world.
Interestingly, about 50% of all pharmaceutical products
distributed in the United States have plant origin. Among
which, very few are used as antimicrobials, since the
microbial sources are widely relied upon (Cowan 1999).
Nevertheless, since the arrival of antibiotics in the 1950s,
the use of plant derivatives as antimicrobials has been lit-
erally non-existent. Researchers are interested in plant
extracts as medicines as they are undisputable substitution
for antibiotics prescribed by physicians (Cowan 1999).
Besides, the public is becoming increasingly aware of
problems with the overuse and misuse of antibiotics. In
addition, many people are attracted in having more
autonomy over their medical care (Cowan 1999). The self-
medication with plant substances is common due to easy
availability. The use of plant-derived natural products in
medical treatments is attracting more attention due to its
potential efficacy and no side effects (Cowan 1999).
Indeed, plants are a rich source of valuable secondary
metabolites, such as quinones, tannins, terpenoids,
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alkaloids, flavonoids, and polyphenols that are used by
plants as defence mechanisms against predation by
microorganisms, insects, and herbivores. Some, such as
terpenoids, give plants their odors; quinones and tannins
are responsible for plant pigmentation. Many compounds
including terpenoids are responsible for plant flavor and
some of the herbs and spices, which are being used by
humans to season foods, could yield useful medicinal
compounds (Cowan 1999; Dixon 2001; Kyaw et al. 2012).
The number of bioactive compounds derived from plants
has been estimated to be at least 200,000 and it still rep-
resents only a fraction of the compounds produced by the
plant species growing on Earth (Efferth and Koch 2011).
Research interest on medicinal plants is being amplified in
recent years, which is seen by the increase in the number of
publications on plant-based pharmacological interactions
and synergistic principles (van Vuuren and Viljoen 2011).
This interest has led to the discovery of new/novel bio-
logically active molecules by the researchers and phar-
maceutical industries and the adoption of crude extracts of
plants for self-medication by the general public. In this
review, an effort is made to summarize one decade
(2005–2015) of plant antimicrobials including the purified
plant-based bioactive compounds, crude and partially
purified plant extracts against MDR human pathogens
including MRSA, MDR-M. tuberculosis and malarial par-
asites Plasmodium spp. This is by no means an exhaustive
search of all plant-derived compounds and plant extracts
during this past 10-year period. Nevertheless, the list pro-
vided in this review is impressive and illustrates the
potential of plant antimicrobials against MDR human
pathogens.
Drug resistance in bacteria: alarming need of new
antibiotics
Antibiotic-resistant bacterial infections are already wide-
spread on the globe (Golkar et al. 2014). In February 2017,
World Health Organization (WHO) published its first ever
list of antibiotic-resistant ‘priority pathogens’ that pose the
greatest threat to human health. The first critical priority
pathogens are carbapenem-resistant Acinetobacter bau-
mannii, carbapenem-resistant Pseudomonas aeruginosa
and carbapenem-resistant and extended spectrum beta-
lactamase (ESBL) producing Enterobacteriaceae. The
second level high priority pathogens are vancomycin-re-
sistant Enterococcus faecium, methicillin-resistant Sta-
phylococcus aureus, clarithromycin-resistant Helicobacter
pylori, fluoroquinolone-resistant Campylobacter spp., flu-
oroquinolone-resistant Salmonellae and cephalosporin and
fluoroquinolone-resistant Neisseria gonorrhoeae. These
priority pathogens are resistant to multiple antibiotics and
have in-built abilities to resist treatment and transfer along
genetic material that leads other bacteria to become drug-
resistant as well (http://www.who.int/mediacentre/news/
releases/2017/bacteria-antibiotics-needed/en/, accessed on
09/05/2017). Therefore, new/novel antibiotics are desper-
ately needed for battling these rapidly evolving pathogens.
The production of new antibiotics has diminished pro-
gressively over the past 20 years, entrusting less possibil-
ities to treat these drug-resistant pathogens (Ventola 2015).
The treatment of infections caused by MDR pathogens is
complicated and limited (Kanj and Kanafani 2011).
Meanwhile, clinicians are still prescribing the existing
drugs with appropriate dosage and combinations of various
drugs for preventing and treating these super bugs (Safavi
et al. 2016). Table 1 displays some of the WHO priority
drug-resistant pathogens and their current antibiotics of
choice for their treatment.
Multi-drug-resistant (MDR) pathogens: a threat
to public health
The underuse, overuse, and misuse of antibiotics by
humans are the selective pressure, which eventually lead to
the development of antibiotic resistance in microbes
(Davies and Davies 2010). Globally, emerging MDR
pathogens also called as ‘ESKAPE’ organisms such as
Enterococcus spp., S. aureus, Klebsiella spp., A. bauman-
nii, P. aeruginosa and Enterobacter spp. are a serious
threat now-a-days to public health (Boucher et al. 2009).
MDR microorganisms can survive the treatment with
antimicrobial drugs, thereby standard treatments become
ineffective and infections persist, increasing the risk of
spread to others. In general, MDR microbes are resistant to
three or more antibiotics (Styers et al. 2006); however,
strains of Mycobacterium tuberculosis are extremely drug-
resistant (XDR) that are virtually resistant to all classes of
antimicrobials (Gandhi et al. 2006). In 2012, WHO
reported a gradual increase in resistance to HIV drugs,
although not reaching critical levels (WHO 2012). Since
then, further increase in resistance to first-line treatment
drugs was reported, which might require using more
expensive drugs soon (http://www.who.int/mediacentre/
factsheets/fs194/en/, accessed on 18/08/2016). In addi-
tion, the Centre for Disease Control (CDC) estimates that
each year, nearly 2 million people in the United States
acquire an infection while in hospital, resulting in 90,000
deaths. More than 70% of the bacteria that cause these
infections are resistant to at least one of the antibiotics
commonly used to treat them (http://www.fda.gov/drugs/
resourcesforyou/consumers/ucm143568.htm, accessed on
18/08/2016). The globally emerging antibiotic resistance,
nevertheless, makes MDR microbes substantially difficult
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to control or kill and also builds them more stronger. It is
clear that the currently available antibiotics are insufficient
to control these superbugs and, hence, more research and
novel antimicrobial sources are highly demanded.
Methicillin-resistant S. aureus (MRSA)
In this decade, the fastest evolving pathogen is MRSA.
There has been a continuous increase in the incidence of
MRSA worldwide. In the United States, current MRSA
rates exceed 50% of all S. aureus infections and stand close
to 90% in some Asian countries (Office for National
Statistics 2005). The mortality rates for deaths involving
MRSA have increased over 15-fold during the period 1993
to 2002 (Office for National Statistics 2005). MRSA has
developed resistance to a number of antibiotics such as
oxacillin, penicillin and amoxicillin. In some countries,
over 60% of S. aureus cases in hospital intensive care units
are now resistant to these first-line antibiotics (Laxmi-
narayan and Malani 2007). MRSA has been categorized
into two groups based on their infections such as hospital-
acquired and community-acquired MRSA (HA-MRSA and
CA-MRSA), which marginally differ in their genetic make-
up.
HA-MRSA is a deadly pathogen and often infects hos-
pitalized patients particularly those who are immuno-
compromised (Sheen 2010). HA-MRSA was first appeared
in the United States in 1968 and showed resistance against
b-lactam antibiotics and other various types of antibiotics
(Chanda et al. 2010). The National Audit Office estimated
that HA-MRSA was the primary factor in 5000 deaths per
annum (National Audit Office 2000). CA-MRSA emerged
in the community setting recovered from a clinical culture
from a patient residing in the surveillance area, who had no
established risk factors usually correlated with HA-MRSA
(Chanda et al. 2010). The established risk factors include
the isolation of MRSA two or more days after hospital-
ization; a history of hospitalization, surgery, dialysis,
chronic diseases, or residence in a long-term care facility
within 1 year before the MRSA-culture date; the presence
of a permanent indwelling catheter or percutaneous medi-
cal device at the time of culture; or previous isolation of
MRSA (Fridkin et al. 2005; Chanda et al. 2010). CA-
MRSA often causes skin infection and severe infection
resulting in fatal on certain occasions displaying resistance
to b-lactam antibiotics, nevertheless susceptible to
trimethoprim/sulfamethoxazole, clindamycin and tetracy-
clines (Deresinski 2005; Chanda et al. 2010).
Staphylococcus aureus is one of the most critical
human pathogens causing wide range of infections from
mild skin diseases to life-threatening endocarditis
(Chambers 2001). After identifying the evidential
occurrence of methicillin resistance among S. aureus
strains, vancomycin and quinolones antibiotics have
been used as alternative drugs of choice as staphylo-
coccal infections therapy (Tiwari et al. 2009). Never-
theless, over a decade, most of the S. aureus strains
including MRSA developed resistance to many com-
monly used fluoroquinolones by acquiring a rapid
mutation in the genes encoding for target enzymes and
expression of the efflux pump (Tanaka et al. 2000; Gade
and Qazi 2013). Looking at the widespread development
of fluoroquinolones resistance in S. aureus (FRSA),
potential antibiotics are required and demand more
awareness in public health care and community settings.
Table 1 List of some WHO priority drug-resistant pathogens and their current antibiotics of choice for treatment
WHO priority drug-resistant pathogen Currently using antibiotics References
Carbapenem-resistant A. baumannii Colistin, carbapenems, sulbactam, rifampin and tigecycline Viehman et al.
(2014)
Carbapenem-resistant P. aeruginosa Ticarcillin-clavulanate, ceftazidime, aztreonam, imipenem, ciprofloxacin
and colistin
Kanj and Kanafani
(2011)
Carbapenem-resistant, ESBL-producing
Enterobacteriaceae
Polymyxins, fosfomycin, carbapenems, tigecycline and aminoglycosides Morrill et al. (2015)
Vancomycin-resistant E. faecium Streptogramin, linezolid, daptomycin, oritavancin and tigecycline Linden (2002)
Methicillin-resistant S. aureus Vancomycin, trimethoprim-sulfamethoxazole, clindamycin, linezolid,
tetracyclines and daptomycin
Kali (2015)
Clarithromycin-resistant H. pylori Amoxicillin, esomeprazole, rabeprazole, omeprazole, metronidazole,
levofloxacin and clarithromycin
Safavi et al. (2016)
Fluoroquinolone-resistant Campylobacter
spp.
Erythromycin, ciprofloxacin and fluoroquinolones Wieczorek and Osek
(2013)
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Table 2 Plant-derived compounds and plant extracts reported during 2005–2015 against multi-drug-resistant pathogens
Compound/extract Plant Source Target Reported
country
References
Aqueous alkaloid,
organic alkaloid and
non-alkaloid
Rhazya stricta Leaves MRSA Saudi
Arabia
Khan et al.
(2016)
Aqueous, chloroform,
ethanol and hexane
Alkanna tinctoria Leaves MRSA, MDR-Acinetobacter
baumannii, E. coli and P.
aeruginosa
Pakistan Khan et al.
(2015)
Dehydroabietic acid P. elliottii Resin-oil MDR-Staphylococcus epidermidis,
S. capitis, S. haemolyticus, E.
faecium and E. faecalis
Brazil Leandro
et al.
(2014)
Dichloromethane,
methanol, petroleum
ether, chloroform,
ethyl acetate, acetone,
ethanol and water
Lantana camara L. Leaves MRSA, VRE, MDR-A. baumannii,
P. aeruginosa, Streptococcus
pyogenes, Citrobacter freundii,
Proteus mirabilis and P. vulgaris
India Dubey and
Padhy
(2013)
Petroleum ether, acetone,
methanol, ethanol and
water
Butea monosperma Lam. Leaves MRSA, VRSA India Sahu and
Padhy
(2013)
Ethanol and water Anthocephalus cadamba and
Pterocarpus santalinus
Leaves and
bark
MDR-Acinetobacter sp., P.
aeruginosa, C. freundii and
Proteus sp.
India Dubey
et al.
(2012)
Ethanol Rhus coriaria Seeds MDR-P. aeruginosa Palestine Adwan
et al.
(2010)
(?)-Lyoniresinol-3
alpha-O-beta-D-
glucopyranoside
Lycium chinense Mill. Roots and
bark
MRSA China Lee et al.
(2005)
Baicalin Scutellaria baicalensis Georgi. NA Synergistic effect with b-lactam-
resistant strains of S. aureus,
synergies between baicalein,
tetracycline, b-lactams and
ciprofloxacin against MRSA and
inhibit MRSA-pyruvate kinase
China Chan et al.
(2011)
Sophoraflavanone G,
7,9,20,40-tetrahydroxy-
8-isopentenyl-5-
methoxychalcone
Sophora flavescens Roots MRSA, VRE China Cha et al.
(2009),
Lee
et al.
(2010)
Chloroform and
chloroform ? HCl
Andrographis paniculata NA MRSA India Roy et al.
(2010)
Hexane Sclerocarya birrea Seeds MRSA Malaysia Mariod
et al.
(2010)
Cold and hot aqueous and
ethanol
Terminalia chebula Retz. Dried
seedless
ripe fruits
MRSA, trimethoprim-
sulphamethoxazole-resistant
uropathogenic E. coli
India Bag et al.
(2009)
20-Hydroxyecdysone Achyranthes japonica Roots MRSA South
Korea
Kim et al.
(2009)
Aqueous and ethanol Fabiana bryoides, F. densa,
F. punensis, Baccharis boliviensis,
Chuquiraga atacamensis,
Parastrephia lepidophylla,
P. lucida, L. phyliciformis,
Frankenia triandra,
Chiliotrichiopsis keidelii
Aerial parts MRSA, MSSA, MRSCN, MSSCN
and MDR-E. faecalis
Argentina Zampini
et al.
(2009)
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Vancomycin-resistant Enterococcus (VRE)
Vancomycin-resistant Enterococcus (VRE) is another cur-
rent threat in emerging drug-resistant pathogens in hospitals
worldwide (Johnstone et al. 2017). Approximately, 66,000
healthcare-associated enterococcal infections are reported in
theUnited States every year. Out of them, approx. 20,000 are
vancomycin-resistant infections with about 1300 deaths
attributes to VRE infections (Centre for Disease Control
2013). Hospital incurred Enterococci infections are resistant
to several drugs including daptomycin, linezolid, penicillin
and cephalosporins, and their progressive resistance has been
Table 2 continued
Compound/extract Plant Source Target Reported
country
References
Limonoids Swietenia mahagoni Seeds MRSA, MDR-Group A haemolytic
S. aureus, Streptococcus
pneumoniae, Haemophilus
influenza, E. coli, Klebsiella
pneumonia, Salmonella typhi and
S. paratyphi
Bangladesh Rahman
et al.
(2009)
Water Punica granatum Pomegranate
rind
MRSA, MSSA,
PVL-positive-CA-MSSA
London Gould
et al.
(2009)
Commercial extract (NA) Olea europaea Leaves MRSA Australia Sudjana
et al.
(2009)
Ellagic acid, norwogonin,
chebulagic acid,
chebulinic acid,
corilagin and
terchebulin
Rosa rugosa, Scutellaria baicalensis
and Terminalia chebula
Commercial
plant
powder
MDR-A. baumannii USA Miyasaki
et al.
(2013)
Triterpenes Planchonia careya Leaves MRSA, VRE Australia McRae
et al.
(2008)
Butanol Retama raetam Flowers MRSA Tunisia Hayet
et al.
(2008)
Ethanol Atuna racemosa Seeds MRSA USA Buenz
et al.
(2007)
Methanol Callistemon rigidus Leaves MRSA India Gomber
and
Saxena
(2007)
Diterpenoids Croton tonkinensis Leaves MRSA Vietnam Giang
et al.
(2006)
Aqueous and 80%
ethanol
Rosa damascena, Melissa officinalis
and Mentha longifolia
Aerial parts
and
flowers
MRSA Palestine Abu-
Shanab
et al.
(2006)
Aqueous and ethanol Terminalia avicennioides, Bridella
ferruginea, Ageratum conyzoides,
Phyllanthus discoideus, Ocimum
gratissimum and Acalypha
wilkesiana
Leaves and
bark
MRSA Nigeria Akinyemi
et al.
(2005)
MRSA methicillin-resistant S. aureus, MDR multi-drug-resistant, VRE vancomycin-resistant enterococci, VRSA vancomycin-resistant S. aureus,
MSSA methicillin-sensitive S. aureus, MRSCN methicillin-resistant Staphylococcus coagulase negative, MSSCN methicillin-sensitive Staphy-
lococcus coagulase negative, PVL-positive-CA-MSSA Panton-Valentine leukocidin positive community-acquired MSSA, NA not accessed
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Table 3 Plant-derived compounds and plant extracts reported during 2005–2015 against MDR-M. tuberculosis
Compound/extract Plant Source Reported
country
References
20% Ethanol Prunella vulgaris L. Whole plant China Lu et al. (2011)
Dihydro-b-agarofuran sesquiter penes Celastrus vulcanicola Dried leaves Spain Torres-Romero
et al. (2011)
n-hexane, ethanol, ethyl acetate, n-butanol,
and methanol extracts
Flourensia cernua Whole plant Mexico Molina-Salinas
et al. (2011)
70% ethanol Allium sativum Cloves Pakistan Hannan et al.
(2011), Dini
et al. (2011)
6a-7-Dehydro-N-formylnornantenine; E/Z-N-
formylnornantenine; 7,9-dimethoxytariacuripyrone;
9-methoxytariacuripyrone; aristololactam I; b-
sitosterol; stigmasterol; 3-hydroxy-a-terpineol
Aristolochia brevipes Roots Mexico Navarro-Garcia
et al. (2011)
Bisbenzylisoquinoline alkaloids Tiliacora triandra Roots Thailand Sureram et al.
(2012)
Alcohol Humulus lupulus Whole plant
(stems,
leaves and
roots)
Iran Serkani et al.
(2012)
Essential oil Citrus sp. NA USA Crandall et al.
(2012)
Obtusifoliol Struthanthus marginatus Aerial parts Brazil Leitao et al.
(2013)3-O-n-acil-lup-20(29)-en-3b,7b,1 5a-triol Struthanthu sconcinnus Leaves Brazil
(-) Licarin A Aristolochia taliscana Roots Mexico Leon-Diaz
et al. (2013)
Ethanol extract Hypericum sp. Aerial parts Portugal Nogueira et al.
(2013)
Ursolic and oleanolic acids Chamaedorea tepejilote Aerial parts Mexico Jimenez-
Arellanes
et al. (2013)
Maritinone and 3,30-biplumbagin Diospyros anisandra Stem and bark Mexico Uc-Cachon
et al. (2014)
70% Ethanol and water eluted part of ethanol extract Ranunculi ternati Radix Whole plant China Zhang et al.
(2015)
Water, methylene chloride, ethanol, n-hexane and ethyl
acetate extracts
Andrographis paniculata, Annona
muricata, Centella asiatica, Pluchea
indica and Rhoeo spathacea
Whole plant
and dried
leaves
Indonesia Radji et al.
(2015)
Diterpenoids including ent-kaurane, kaurane and
grayanane
Water extract
Croton tonkinensis Whole plants
or leaves
South
Korea
Jang et al.
(2016),
Gupta et al.
(2010)
Acalypha indica L. Leaves India
Adhatoda vasica Leaves India
Allium cepa Bulbs India
Allium sativum L. Cloves India
Pure gel of Aloe vera Aloe vera L. Pure gel India Gupta et al.
(2012)
Ethyl p-methoxycinnamate Kaempferia galanga Rhizome India Lakshmanan
et al. (2011)
Piperine Piper nigrum L. Seeds India Birdi et al.
(2012)
5,10-Pentadecadiyn-1-ol, a-curcumene,
hydroxyjunipene, cycloisosativene, valencine and
selino 3,7 (11)-diene
Vetiveria zizanioides Fresh roots India Gupta et al.
(2012)
Alkaloids, flavonoids Urtica dioica Leaves India Singh et al.
(2013)
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discovered across the world posing an alarming concern
(Simeon et al. 2006; Johnstone et al. 2017).
Table 2 summarizes 15 plant-derived compounds and
40 plant extracts reported during 2005–2015 against MDR
pathogens including MRSA, VRE, Trimethoprim–sul-
phamethoxazole-resistant uropathogenic Escherichia coli
and various MDR Gram-negative and MDR Gram-positive
human pathogens. This list clearly demonstrates the sub-
stantive and ongoing role of plant-derived compounds
against MRSA and other MDR pathogens. A total of 43
plants are reviewed in Table 2; they are belonging to 23
different families. Interestingly, out of the 43 plants, 42 are
angiosperms excluding the Brazilian Pinus elliottii (Lean-
dro et al. 2014). Results show that both angiosperms and
gymnosperms harboring potential antimicrobials against
MDR pathogens; nevertheless, angiosperms are widely
studied against MDR pathogens.
Multi-drug-resistant tuberculosis (MDR-TB)
Tuberculosis (TB) is an extremely notorious and infectious
disease caused by Mycobacterium spp., particularly M.
tuberculosis. TB is the second most fatal disease after HIV,
accountable for human deaths across the globe according to
the World Health Organization (WHO 2014). Around 6.1
million TB patients have been reported in the year 2013, of
these, about 5.7 million (93%) cases were new (WHO
2014). About 9.6 million people were reported ill due to
TB in 2014, of which approximately 1.5 million died
(WHO 2014; Pandit et al. 2015). This disease is highly
progressive in Asia and Africa, and more than 80% of all
TB cases were reported from these two continents (Zager
and McNerney 2008). Evidently, the M. tuberculosis is
acquiring resistance against conventional drugs, thus
frightening the global health community (Zignol et al.
2006). MDR-M. tuberculosis requires treatment courses
that are much longer and less effective than those for non-
resistant M. tuberculosis. Extensively drug-resistant TB
(XDR-TB, defined as MDR-TB plus resistance to any
fluoroquinolone and any second-line injectable drugs) has
been identified in 100 countries, in all regions of the world
(http://www.who.int/mediacentre/factsheets/fs194/en/, acces-
sed on 18/08/2016). In this review, we have outlined plant-
derived compounds and plant derivatives having significant
anti-mycobacterial activity against MDR-TB reported during
2005–2015 (Table 3). Table 3 covers a total of 34 plants
belonging to 26 different families and all are angiosperms. A
total of 36 purified compounds and 20 plant extracts were
reported during 2005–2015 against MDR-M. tuberculosis.
These data obviously revealed that the plant-derived antimi-
crobials have a unique competence, as well as alternative and
novel solutions to control these deadly MDR- and XDR-TB.
Malaria: a current public health concern
Malaria is a complex deadly blood disease with ravaging
effects in the world (Ongue´ne´ et al. 2013). Approximately,
half of the world’s population is at risk of malaria and that
1–2 million annual deaths can be attributed to malaria
alone (Vogel 2010; WHO 2012; Ongue´ne´ et al. 2013).
There were approximately 245 million cases of malaria in
2006 and 3.3 billion people were at risk of the disease.
Among them, about 1 million deaths were mostly of chil-
dren under the age of five (Oliviera et al. 2009). Currently,
there are 109 malarious countries and territories, of which,
45 are within the African region (WHO 2008). A total of
four protozoan species of the genus Plasmodium (P. fal-
ciparum, P. malariae, P. ovale, and P. vivax) are the
causative agents for this infection, although majority of
fatal cases are caused by P. falciparum (Nogueira and
Lopes 2011). Currently, malaria has been treated with
Table 3 continued
Compound/extract Plant Source Reported
country
References
Plumericin and iso-Plumericin Plumeria bicolor Bark India Kumar et al.
(2013)
Emodin Ventilago madraspatana Stem and bark India Basu et al.
(2005)
Diospyrin Diospyros montana Stem and bark India Dey et al.
(2014)
Andrographolide Andrographis paniculata Whole plant India Prabu et al.
(2015)
Aqueous, boiling water and methanol extracts Punica granatum Fruit India Dey et al.
(2015)
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Table 4 Plant-derived compounds and plant extracts reported during 2005–2015 for anti-plasmodial activity
Compound Plant Source Reported
country
References
17-O-acetyl,10-hydroxycorynantheol Strychnos
usambarensis
Leaves Belgium Cao et al. (2011)
Alstonine Picralima nitida Fruits USA Okunji et al. (2005)
Methyl uguenenoate, furoquinoline and maculosidine Vepris uguenensis Roots South
Africa
Cheplogoi et al. (2008),
Kiplimo (2012)
Evoxine, arborinine and xanthoxoline Teclea gerrardii Roots, bark
and fruits
South
Africa
Waffo et al. (2007),
Tchinda et al. (2009)
N-isobutyldeca-2,4-dienamide Hugonia
castaneifolia
Root and bark Tanzania Baraza et al. (2008)
Pipyahyine Beilschmiedia
zenkeri
Bark France Lenta et al. (2009)
Cryptoquindoline Cryptolepis
sanguinolenta
Stems Ghana Barku et al. (2012)
Clerodane and labdane diterpenoids Nuxia
sphaerocephala
Leaves Sudan Mambu et al. (2006)
16-Oxolabda-8(17),12(E)-dien-15-oic acid, methyl-14,15-
epoxylabda-8(17), 12(E)-Diene-16-oate and Turraeanin A
Turreanthus
africanus
Seeds Cameroon Ngemenya et al. (2006)
3-Deoxyaulacocarpin A, Zambesiacolactones A and B,
aulacocarpin A
Aframomum
zambesiacum
Seeds Cameroon Kenmogne et al. (2006)
Galanal B, galanolactone, (E)-8,17-epoxylabd-12-ene-5,16 dial
and (E) Labda-8,12-diene-15,16 dial
Aframomum
arundinaceum
Seeds Cameroon Wabo et al. (2006)
7a-Obacunylacetate, 7a-acetoxydihydronomilin,
22-hydroxyhopan-3-one and 24-methylene cycloartenol
Entandrophragma
angolense
Stem and bark Cameroon Bickii et al. (2007)
7-Deacetoxy-7-oxogedunin, Ekeberin C1–C3 and acyclic
triterpenes
Ekebergia capensis Stem and bark Japan Murata et al. (2008)
Bisnorterpenes Salacia
madagascariensis
Roots USA Thiem et al. (2005)
Cassane furanoditerpenes Caesalpinia
volkensii
Root and bark Kenya Ochieng et al. (2012)
Abietane diterpenes Plectranthus spp. Leaves South
Africa
Van Zyla et al. (2008)
Ferruginol Fuerstia africana Aerial parts USA Koch et al. (2006)
13-Epi-dioxiabiet-8(14)-en-18-ol Hyptis suaveolens Leaves South
Africa
Chukwujekwu et al.
(2005)
Sesquiterpenes Acanthospermum
hispidum
Flowers,
leaves and
stems
Belgium Ganfon et al. (2012)
Vernangulides A, B, Vernodalol and Vernodalin Vernonia
angulifolia
Aerial parts Denmark Pedersen et al. (2009)
Urospermal A-15-O-acetate Dicoma tomentosa Whole plant Belgium Jansen et al. (2012)
Artemisinin Artemisia annua Seeds Italy Reale et al. (2008)
Dehydrobrachylaenolide Dicoma anomala
subsp. gerrardii
Roots stocks South
Africa
Becker et al. (2011)
Okundoperoxide Scleria striatinux Roots Cameroon Efange et al. (2009)
Coloratane sesquiterpenes Warburgia
ugandensis
Stem and bark Austria Wube et al. (2010)
Beilshmiedic acid derivatives Beilschmiedia
cryptocaryoides
Bark Germany Talontsi et al. (2013)
3-Hydroxy-20(29)-lupen-28-ol Schefflera
umbellifera
Leaves South
Africa
Mthembu (2007)
Pristimerin Maytenus
senegalensis
Root and bark Sudan Khalid et al. (2007)
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quinine, chloroquine, mefloquine and artemisinin among
other drugs (Ongue´ne´ et al. 2013). However, the proto-
zoans have developed resistance in many countries of the
world over time towards the influential factors: poor
hygienic conditions, poorly managed vector control pro-
grammes and no approved vaccines so far (White 2004).
Researchers currently put their research efforts on new
antimalarial agents, mainly focusing on natural origin and
the development of phytomedicines (Ongue´ne´ et al. 2013).
Table 4 reviews the plant-derived compounds including
alkaloids, terpenoids and triterpenoids for antimalarial
properties. A total of 59 anti-plasmodial compounds
including a potent antimalarial drug artemisinin were
reported from different plants documented during
2005–2015 (Table 4). Notably, Table 4 displays a total of
35 plants belonging to 21 families under angiosperms
showing antimalarial activity. The data summarized in the
Table 4 highlight the rich diversity of plant natural prod-
ucts that manifest to be a promising source for the devel-
opment of antimalarial agents.
Drug discovery from plants
The concept of ‘the active principle’ inmedicine first reported
in the fifteenth century; however, pure compounds isolated
from the plant extractswere reported in the late eighteenth and
earlier nineteenth century (Houghton 2001). It is important to
note that plant-derived pure compounds had the similar effect
as the plant extract and thusbeenpromptly substituted inmany
cases as the important ingredient in medicines (Houghton
2001). Codeine and narcotine were the first natural com-
pounds isolated from Papaver somniferum. Since then,
numbers of compounds have been isolated from plants and
many of these remain in extensive use in medicine as drugs
(Houghton 2001; Lahlou 2013). Some of the prominent plant-
derived commercially proven drugs, sources, brand names
and their medicinal uses are shown in Table 5. Plant-derived
molecules including secondary metabolites that demonstrate
medicinal properties may act by similar or different mecha-
nisms. The mode of antimicrobial action is similar between
plant-derivedquinones (bind to adhesions, inactivate enzymes
and complexwith cell wall) and flavonoids (bind to adhesions
and complex with cell wall). However, polyphenols and tan-
nins (enzyme inhibition, substrate deprivation, membrane
disruption and metal ion complexation), terpenoids and
essential oils (membrane disruption) and alkaloids (intercalate
into cellwall) antimicrobial actions are varied in theirmode of
action (Pandey and Kumar 2013).
A total of 112 plants were studied during the period
2005–2015 of which, 110 purified bioactive compounds and
60 plant-derived extracts were reported and displayed sig-
nificant antibacterial, antitubercular, and antimalarial
activities (Tables 2, 3, 4). Totally, 40 and 20 plant extracts
were reported for antibacterial and antitubercular activities,
respectively, during this period (Tables 2, 3, 4). Although
these plant extracts showed same therapeutic effects as pure
compounds, further investigation of structural elucidation
would afford novel chemical structures and new drugs.
Plants reviewed in this study are reported from 36 countries
around the world. Out of 112 plants, 41.96, 25.00, 10.71,
11.60, 8.90 and 1.78% were reported from Asia, Africa,
Europe, North America, South America and Oceania,
respectively (Fig. 1). Asia, the highest number (20) of plants,
is reported for India for antibacterial and antitubercular
activities in the period 2005–2015. Besides, the 112 plants
revised in this study belong to 70 different plant families and
99% of them are angiosperms, which is displaying the
Table 4 continued
Compound Plant Source Reported
country
References
Pentacyclic triterpenes Nuxia
sphaerocephala
Leaves Sudan Mambu et al. (2006)
Lupeol and Lupeyl docosanoate Hymenocardia
acida
Bark and
stems
Nigeria Mahmout et al. (2008),
Ajaiyeoba et al. (2008)
Betulinic acid Hypericum
lanceolatum
Stem and bark Cameroon Zofou et al. (2011)
3-Friedelanone Psorospermum
glaberrimum
Stem and bark Germany Lenta et al. (2008)
3-O-betulinic acid p-coumarate Baillonella
toxisperma
Stem and bark Cameroon Mbah et al. (2011)
2b,3b,19a-Trihydroxy-urs-12-20-en-28-oic acid Kigelia africana Stem and bark Cameroon Zofou et al. (2012)
Cucurbitacins B, D and 20-epibryonolic acid Cogniauxia
podolaena
Stem and bark Congo Banzouzi et al. (2008)
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therapeutic potential. Houghton (2001) reported that 25% of
the drugs prescribed by physicians in the developed coun-
tries are obtained from flowering plants, angiosperms.
Among the 70 families recorded, plants from Apocynaceae,
Lamiaceae and Asteraceae showed antibacterial, antituber-
cular, and antimalarial activities, while plants from Acan-
thaceae, Lythraceae, and Euphorbiaceae disclosed
antibacterial and antitubercular activities. However, plants
from Fabaceae and Meliaceae exhibited antibacterial and
antimalarial activities, but plants belonging to Celastraceae,
Rutaceae, Hypericaceae and Zingiberaceae demonstrated
antitubercular and antimalarial activities. The plant-derived
extracts mentioned in this review were from various organic
solvent extracts including aqueous extracts (Tables 2, 3).
Furthermore, the total number of purified compounds given
in this review is not an exact number reported in the men-
tioned period because we also have provided the class of
compounds which may contain number of derivatives.
Nevertheless, the data collected in this review impose and
focus the value of plant antimicrobials against the lethal
MDR pathogens including malarial parasites.
Future perspectives
Plants are the renowned natural laboratories for producing
structurally unique, diverse and complex natural products.
Besides the plants, extensive efforts are also being
Table 5 Some of the drugs obtained from plants
Drug Brand/trade name Plant source Medicinal use
Amitriptylin Amitrip, Elavil, Levate Hypericum perforatum L. Mental illnesses, migraines, fibromyalgia
Midazolam Versed, Dormicum, Hypnovel Hypericum perforatum L. Anesthesia, procedural sedation, trouble sleeping
Nevirapine Viramune Hypericum perforatum L. Antiretroviral therapy to treat HIV/AIDS
Paroxetine Paxil, Pexeva, Seroxat,
Brisdelle, Rexetin
Hypericum perforatum L. Antidepressant drug
Cyclosporine Neoral, Sandimmune Hypericum perforatum L. Rheumatoid arthritis, Psoriasis, Crohn’s disease,
Nephrotic syndrome
Tacrolimus Prograf, Advagraf, Protopic Hypericum perforatum L. Immunosuppressive drug
Simvastatin Zocor Hypericum perforatum L. Lipid-lowering medication
Alprazolam Xanax, Niravam Piper methysticum G. Forst. Anxiety disorders
Atropine Atropen Atropa belladonna, Hyoscyamus spp.,
Datura spp.
Antispasmodic for gastrointestinal tract, Pupil
enlargement in eye
Pilocarpine Isopto Carpine, Salagen Pilocarpus jaborandi Glaucoma Treatment, Pupil contraction in eye
Indinavir Crixivan Hypericum perforatum L. Antiretroviral therapy to treat HIV/AIDS
Sertraline Zoloft Hypericum perforatum L. Antidepressant drug
Scopolamine Transdermscop, Kwells Atropa belladonna, Hyoscyamus spp.,
Datura spp.
Preoperative Sedative, Antiemetic in travel sickness
Caffeine Vivarin, Cafcit, Alert Coffea arabica, Thea sinensis Psychoactive drug, Central nervous system (CNS)
stimulant
Digoxin Lanoxin Digitalis lanata Improvement in force of contraction to remedy
congestive heart failure
Ephedrine Bronkaid, Primatene Ephedra spp. Relief of asthma and hay fever
Paclitaxel Taxol Taxus brevifolia Chemotherapy medication used to treat number of
types of cancer
Quinine Qualaquin, Quinate, Quinbisul Cinchona spp. Antimalarial drug
Carbamazepin Tegretol Plantago sp. Epilepsy, Neuropathic pain
Clopidogrel Plavix Ginkgo biloba Heart disease, stroke
Reserpine Raudixin, Serpalan, Serpasil Rauwolfia spp. Antipsychotic, Antihypertensive drug
Phenelzin Nardil, Nardelzine Panax ginseng Antidepressant and anxiolytic drug
Vinblastine Velban Catharanthus roseus Chemotherapy medication used to treat number of
types of cancer
Prednisolon Orapred, Prelone, PediaPred,
Millipred
Glycyrrhiza glabra Allergies, inflammatory conditions, autoimmune
disorders
Hydrocortisone Cortef, Solu-Cortef Glycyrrhiza glabra Thyroiditis, rheumatoid arthritis, dermatitis, asthma
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undertaken on microorganisms and other organisms from
another living world, such as the oceans (Subramani and
Aalbersberg 2013; Malve 2016) for pharmaceutically
important biomolecules. However, in plants particularly
angiosperms, only less than 10% have been screened for
natural products discovery (Houghton 2001). Therefore,
there is an immense scope for more fascinating bioactive
compounds from flowering plants that will yield new/novel
drugs. To access this hidden treasure, more integrative
approach with various natural product discovery tools will
be the key for success in discovery of phytomedicines. The
complex and rich chemical diversity in plants pave to the
isolation of natural products which is tough and laborious.
Therefore, the significant application of tools such as high-
performance liquid chromatography coupled to mass
spectrometry (HPLC–MS), liquid chromatography–mass
spectrometry (LC–MS), liquid chromatography–nuclear
magnetic resonance–mass spectrometry (LC–NMR–MS),
capillary NMR (cap-NMR) spectroscopy, LC–solid phase
extraction (SPE)–NMR along with bioassay-guided frac-
tionation and high-throughput bioassays will accelerate the
access of plant-derived natural products. However, the
substantial use of medicinal plants for drug discovery
programme endangers their existence, so farming of
medicinal plants must be instigated for assuring the future
accountability (Lahlou 2013).
Conclusion
The use of herbs and herbal products has widely been
accepted in our modern way of life and it is estimated that
about 80% of the world’s population still rely on traditional
medicines for their primary health care. The significance of
plant-derived natural products and their extracts used by
the lay community has been realized and documented since
ancient time. Interestingly, researchers and clinicians pay
great attention to plant-derived secondary metabolites
because of their antibiotic activity without conferring any
antibiotic resistance. Hence, plant-based antimicrobials
have widely been used as preventative and curative solu-
tions against multi-drug-resistant pathogens. Globally
emerging MDR and XDR pathogens are a serious concern.
On the other hand, most of the chemically synthesised
antibiotics can cause adverse side effects and are very
expensive. Therefore, these days, there is an increasing
inclination towards the use of an alternative source of
medicines, particularly the medicinal plants. Several plant
species have already been widely reported showing
potential medicinal properties. However, the emerging new
infections, diseases and rapid evolution of pathogens urge
the researchers for further exploration into nature for novel
natural products. Plants are certainly playing a dynamic
role to control antibiotic-resistant bacterial infections.
However, these plant-derived active principles should be
taken for further research to translate this knowledge into
potential therapeutic drugs.
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